Matsui Connie - Net Worth and Insider Trading
Matsui Connie Net Worth
The estimated net worth of Matsui Connie is at least $15 Million dollars as of 2024-11-13. Matsui Connie is the Director of Halozyme Therapeutics Inc and owns about 181,983 shares of Halozyme Therapeutics Inc (HALO) stock worth over $11 Million. Matsui Connie is the EVP, Corp. Strategy and Comm. of Biogen Inc and owns about 22,571 shares of Biogen Inc (BIIB) stock worth over $4 Million. Matsui Connie is also the Director of Artelo Biosciences Inc and owns about 3,778 shares of Artelo Biosciences Inc (ARTL) stock worth over $4,420. Details can be seen in Matsui Connie's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matsui Connie has not made any transactions after 2021-11-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matsui Connie
Matsui Connie Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matsui Connie owns 4 companies in total, including Halozyme Therapeutics Inc (HALO) , Sutro Biopharma Inc (STRO) , and Artelo Biosciences Inc (ARTL) among others .
Click here to see the complete history of Matsui Connie’s form 4 insider trades.
Insider Ownership Summary of Matsui Connie
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HALO | Halozyme Therapeutics Inc | 2021-11-05 | director |
STRO | Sutro Biopharma Inc | 2019-06-24 | director |
ARTL | Artelo Biosciences Inc | 2020-05-04 | director |
2007-01-16 | EVP - Corp Comm & Strategy |
Matsui Connie Latest Holdings Summary
Matsui Connie currently owns a total of 3 stocks. Among these stocks, Matsui Connie owns 181,983 shares of Halozyme Therapeutics Inc (HALO) as of November 5, 2021, with a value of $11 Million and a weighting of 74.05%. Matsui Connie owns 22,571 shares of Biogen Inc (BIIB) as of January 16, 2007, with a value of $4 Million and a weighting of 25.92%. Matsui Connie also owns 3,778 shares of Artelo Biosciences Inc (ARTL) as of May 4, 2020, with a value of $4,420 and a weighting of 0.03%.
Latest Holdings of Matsui Connie
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HALO | Halozyme Therapeutics Inc | 2021-11-05 | 181,983 | 59.64 | 10,853,466 |
BIIB | Biogen Inc | 2007-01-16 | 22,571 | 168.28 | 3,798,248 |
ARTL | Artelo Biosciences Inc | 2020-05-04 | 3,778 | 1.17 | 4,420 |
Holding Weightings of Matsui Connie
Matsui Connie Form 4 Trading Tracker
According to the SEC Form 4 filings, Matsui Connie has made a total of 2 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Halozyme Therapeutics Inc is the sale of 32,000 shares on November 5, 2021, which brought Matsui Connie around $1 Million.
According to the SEC Form 4 filings, Matsui Connie has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 24,823 shares on January 16, 2007, which brought Matsui Connie around $1 Million.
According to the SEC Form 4 filings, Matsui Connie has made a total of 1 transactions in Artelo Biosciences Inc (ARTL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Artelo Biosciences Inc is the acquisition of 2,778 shares on May 4, 2020, which cost Matsui Connie around $50,000.
Insider Trading History of Matsui Connie
- 1
Matsui Connie Trading Performance
GuruFocus tracks the stock performance after each of Matsui Connie's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matsui Connie is -7.88%. GuruFocus also compares Matsui Connie's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matsui Connie within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matsui Connie's insider trading performs compared to the benchmark.
Performance of Matsui Connie
Matsui Connie Ownership Network
Ownership Network List of Matsui Connie
Ownership Network Relation of Matsui Connie
Matsui Connie Owned Company Details
What does Halozyme Therapeutics Inc do?
Who are the key executives at Halozyme Therapeutics Inc?
Matsui Connie is the director of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & Chief Financial Officer Nicole Labrosse .
Halozyme Therapeutics Inc (HALO) Insider Trades Summary
Over the past 18 months, Matsui Connie made no insider transaction in Halozyme Therapeutics Inc (HALO). Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 280,000 shares made by Michael J. Labarre , a net sale of 200,000 shares made by Helen Torley , and a net sale of 49,881 shares made by Matthew L. Posard .
In summary, during the past 3 months, insiders sold 199,881 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 199,881 shares. During the past 18 months, 584,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 584,881 shares.
Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Halozyme Therapeutics Inc Insider Transactions
Matsui Connie Mailing Address
Above is the net worth, insider trading, and ownership report for Matsui Connie. You might contact Matsui Connie via mailing address: 3030 Callan Rd, San Diego Ca 92121.